<p>佛罗里达州劳德代尔堡，2026 年 1 月 8 日（GLOBE NEWSWIRE）-- <strong>SS Innovations International, Inc.</strong> <strong>（“公司” 或 “SS Innovations”）（纳斯达克：SSII）</strong>，一家致力于使机器人手术变得经济实惠和可及的创新外科机器人技术开发商，今天宣布任命米兰·拉奥（Milan Rao）为公司的全球首席运营官和首席财务官。全球首席运营官的职位是新设立的职位。拉奥先生将接替因个人原因辞职的纳维恩·库马尔·阿马尔（Naveen Kumar Amar）担任首席财务官。拉奥先生将驻美国，并将在计划的过渡期间与董事长和执行领导团队密切合作。</p>
<p>拉奥先生为 SS Innovations 带来了超过三十年的高管领导经验，推动技术驱动的转型、运营效率和在各行业领先全球公司的增长，包括医疗保健领域。在他的职业生涯中，他在管理全球运营、跨职能团队、财务报表和预算、并购活动以及资本配置策略方面积累了丰富的专业知识，以扩大平台并实现盈利增长。</p>
<p>SS Innovations 董事会主席兼首席执行官苏迪尔·斯里瓦斯塔瓦（Dr. Sudhir Srivastava）评论道：“米兰为 SS Innovations 带来了卓越的业绩记录，通过他的亲身领导方式建立高绩效团队和发展跨国企业。他的任命反映了我们吸引顶尖人才加入我们的执行团队的承诺，因为我们继续扩大我们先进、经济实惠的 SSi Mantra 外科机器人系统的全球足迹。米兰将在定义我们的增长战略和兑现我们为更广泛的需要患者群体民主化机器人手术的承诺中发挥重要作用。”</p>
<p>拉奥先生补充道：“我很高兴能在这个过渡期间与斯里瓦斯塔博士和 SS Innovations 领导团队合作。SS Innovations 建立了一个引人注目且独特的机器人平台，我期待为公司的战略方向、运营准备和长期价值创造做出贡献，因为组织将继续发展和扩展。”</p>
<p>最近，拉奥先生担任全球研究和咨询公司 Markets and Markets 的首席运营官和首席收入官。在此之前，他曾担任多个高级全球领导职务，包括云计算 SaaS 公司 Smart Energy Water 的总裁和全球业务负责人；全球领先技术服务公司 Wipro Limited 的总裁；以及 GE Healthcare 印度及新兴市场的总裁兼首席执行官。在他的职业生涯早期，拉奥先生通过在摩根士丹利和花旗银行的领导角色获得了丰富的金融和资本市场经验。</p>
<p>拉奥先生毕业于印度理工学院（瓦拉纳西印度教大学）计算机科学与工程专业，获得理学学士学位，并被评为杰出校友，同时获得印度管理学院加尔各答的金融与市场工商管理硕士学位。</p>
<p><strong>关于 SS Innovations</strong></p>
<p>SS Innovations International, Inc.（纳斯达克：SSII）开发创新的外科机器人技术，旨在使机器人手术的好处对更大范围的全球人群变得经济实惠和可及。公司的产品范围包括其专有的 “SSi Mantra” 外科机器人系统和全面的 “SSi Mudra” 外科器械套件，支持包括心脏手术在内的多种机器人外科手术。SS Innovations 是一家总部位于印度的美国公司，计划扩大其技术先进、用户友好且经济实惠的外科机器人解决方案的全球影响力。有关更多信息和更新，请访问公司的官方网站 ssinnovations.com 或 LinkedIn。</p>
<p><strong>关于 SSi Mantra</strong></p>
<p>SSi Mantra 外科机器人系统是一个用户友好、模块化的多臂系统，具有许多先进的技术特性，包括：3 到 5 个模块化机器人手臂、开放式的人体工学外科医生指挥中心、大型 3D 4K 显示器、用于显示所有患者相关信息的触摸面板监视器、机器人患者侧手臂小车的虚拟实时图像，以及叠加诊断影像 3D 模型的能力。视觉车为桌边团队提供与外科医生相同的放大 3D 4K 视图，以提供更好的安全性和效率。SSi Mantra 利用超过 40 种不同类型的机器人内镜外科器械，支持包括心脏手术在内的不同专业。SSi Mantra 在印度的 100 多种不同类型的外科手术中得到了临床验证。</p>
<p><strong>前瞻性声明</strong></p>
<p>本新闻稿可能包含不属于历史事实的声明，并被视为 1995 年《私人证券诉讼改革法案》意义上的前瞻性声明。用 “预期”、“假设”、“相信”、“估计”、“期望”、“将”、“打算”、“可能”、“计划”、“项目”、“应该”、“可以”、“寻求”、“设计”、“潜在”、“预测”、“目标”、“目的”、“目标” 或这些术语的否定形式或其他类似表达来识别这些前瞻性声明。这些声明涉及未来事件或 SS Innovations 的未来财务表现，并涉及已知和未知的风险、不确定性和其他因素，这些因素可能导致我们的实际结果、活动水平、表现或成就与这些前瞻性声明所表达或暗示的任何未来结果、活动水平、表现或成就有实质性不同。</p>
<p><strong>投资者联系：</strong></p>
<p>Equity Group</p>
<p>Kalle Ahl, CFA</p>
<p>电话：（303）953-9878</p>
<p>kahl@theequitygroup.com</p>
<p>德文·沙利文，董事总经理</p>
<p>电话: (212) 836-9608</p>
<p>电子邮件: dsullivan@theequitygroup.com</p>
<p><strong>媒体联系人：</strong></p>
<p>RooneyPartners LLC</p>
<p>Kate Barrette</p>
<p>电话: (212) 223-0561</p>
<p>电子邮件: kbarrette@rooneypartners.com</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU1qWXlNQ00zTXpVeU16Z3dJelV3TURFeU1ETTBPQT09?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU1qWXlNQ00zTXpVeU16Z3dJelV3TURFeU1ETTBPQT09"/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGVkOTQ3ODUtYzk5ZS00YTNiLTlhNGYtODY1MGU1MGI4NWJhLTUwMDEyMDM0OC0yMDI2LTAxLTA4LWVu/tiny/SS-Innovations.png?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGVkOTQ3ODUtYzk5ZS00YTNiLTlhNGYtODY1MGU1MGI4NWJhLTUwMDEyMDM0OC0yMDI2LTAxLTA4LWVu/tiny/SS-Innovations.png"/></p>

SSII

<p>SS Innovations International, Inc. 任命 Milan Rao 为全球首席运营官和首席财务官，接替 Naveen Kumar Amar。这个新设立的首席运营官职位将使 Rao 与执行团队紧密合作，以增强公司的增长战略和运营效率。Rao 在技术和医疗保健领域拥有超过 30 年的经验，曾在多家全球公司担任领导职务。他的任命反映了 SS Innovations 扩大其在机器人手术技术领域全球影响力的承诺</p>

<p>FORT LAUDERDALE, Fla., Jan. 08, 2026 (GLOBE NEWSWIRE) -- <strong>SS Innovations International, Inc.</strong> <strong>(the “Company” or “SS Innovations”) (Nasdaq: SSII)</strong>, a developer of innovative surgical robotic technologies dedicated to making robotic surgery affordable and accessible to a global population, today announced the appointment of Milan Rao as the Company’s Global Chief Operating Officer and Chief Financial Officer. The Global Chief Operating Officer role is a newly created position. Mr. Rao will succeed Naveen Kumar Amar as Chief Financial Officer following Mr. Amar’s resignation from the Company for personal reasons. Mr. Rao will be based in the United States and will work closely with the Chairman and executive leadership team during a planned transition period.</p>
<div class="lb-trans"><p>佛罗里达州劳德代尔堡，2026 年 1 月 8 日（GLOBE NEWSWIRE）-- <strong>SS Innovations International, Inc.</strong> <strong>（“公司” 或 “SS Innovations”）（纳斯达克：SSII）</strong>，一家致力于使机器人手术变得经济实惠和可及的创新外科机器人技术开发商，今天宣布任命米兰·拉奥（Milan Rao）为公司的全球首席运营官和首席财务官。全球首席运营官的职位是新设立的职位。拉奥先生将接替因个人原因辞职的纳维恩·库马尔·阿马尔（Naveen Kumar Amar）担任首席财务官。拉奥先生将驻美国，并将在计划的过渡期间与董事长和执行领导团队密切合作。</p>
</div><p>Mr. Rao brings to SS Innovations more than three decades of executive leadership experience driving technology-enabled transformation, operational efficiency and growth at leading global companies across industries, including the healthcare sector. During his career, he has developed expertise in managing worldwide operations, cross-functional teams, financial statements and budgets, M&amp;A activities, and capital allocation strategies to scale platforms and deliver profitable growth.</p>
<div class="lb-trans"><p>拉奥先生为 SS Innovations 带来了超过三十年的高管领导经验，推动技术驱动的转型、运营效率和在各行业领先全球公司的增长，包括医疗保健领域。在他的职业生涯中，他在管理全球运营、跨职能团队、财务报表和预算、并购活动以及资本配置策略方面积累了丰富的专业知识，以扩大平台并实现盈利增长。</p>
</div><p>Dr. Sudhir Srivastava, Chairman of the Board and Chief Executive Officer of SS Innovations, commented, “Milan brings to SS Innovations a commendable track record of building high-performance teams and growing multinational businesses through his hands-on leadership approach. His appointment reflects our commitment to attracting top talent to our executive team as we continue to expand the global footprint of our advanced, cost-effective SSi Mantra surgical robotic system. Milan will play an integral role in defining our growth strategy and delivering on our promise of democratizing robotic surgery for a broader segment of patients in need.”</p>
<div class="lb-trans"><p>SS Innovations 董事会主席兼首席执行官苏迪尔·斯里瓦斯塔瓦（Dr. Sudhir Srivastava）评论道：“米兰为 SS Innovations 带来了卓越的业绩记录，通过他的亲身领导方式建立高绩效团队和发展跨国企业。他的任命反映了我们吸引顶尖人才加入我们的执行团队的承诺，因为我们继续扩大我们先进、经济实惠的 SSi Mantra 外科机器人系统的全球足迹。米兰将在定义我们的增长战略和兑现我们为更广泛的需要患者群体民主化机器人手术的承诺中发挥重要作用。”</p>
</div><p>Mr. Rao added, “I am pleased to begin working with Dr. Srivastava and the SS Innovations leadership team during this transition. SS Innovations has built a compelling and differentiated robotics platform and I look forward to contributing to the Company’s strategic direction, operational readiness and long-term value creation as the organization continues to evolve and scale.”</p>
<div class="lb-trans"><p>拉奥先生补充道：“我很高兴能在这个过渡期间与斯里瓦斯塔博士和 SS Innovations 领导团队合作。SS Innovations 建立了一个引人注目且独特的机器人平台，我期待为公司的战略方向、运营准备和长期价值创造做出贡献，因为组织将继续发展和扩展。”</p>
</div><p>Most recently, Mr. Rao has been serving as Chief Operating Officer and Chief Revenue Officer of Markets and Markets, a global research and consulting firm. Prior to that, he held senior global leadership roles including President and Global Business Head of Smart Energy Water, a cloud-based SaaS company; President of Wipro Limited, a leading global technology services firm; and President &amp; CEO for India &amp; Emerging markets at GE Healthcare. Earlier in his career, Mr. Rao gained significant financial and capital markets experience through leadership roles at Morgan Stanley and Citibank.</p>
<div class="lb-trans"><p>最近，拉奥先生担任全球研究和咨询公司 Markets and Markets 的首席运营官和首席收入官。在此之前，他曾担任多个高级全球领导职务，包括云计算 SaaS 公司 Smart Energy Water 的总裁和全球业务负责人；全球领先技术服务公司 Wipro Limited 的总裁；以及 GE Healthcare 印度及新兴市场的总裁兼首席执行官。在他的职业生涯早期，拉奥先生通过在摩根士丹利和花旗银行的领导角色获得了丰富的金融和资本市场经验。</p>
</div><p>Mr. Rao graduated with a Bachelor of Science degree in Computer Science &amp; Engineering from the Indian Institute of Technology (Banaras Hindu University) Varanasi, where he has been recognized as a Distinguished Alumnus, and a Master of Business Administration degree in Finance &amp; Marketing from the India Institute of Management Calcutta.</p>
<div class="lb-trans"><p>拉奥先生毕业于印度理工学院（瓦拉纳西印度教大学）计算机科学与工程专业，获得理学学士学位，并被评为杰出校友，同时获得印度管理学院加尔各答的金融与市场工商管理硕士学位。</p>
</div><p><strong>About SS Innovations</strong></p>
<div class="lb-trans"><p><strong>关于 SS Innovations</strong></p>
</div><p>SS Innovations International, Inc. (Nasdaq: SSII) develops innovative surgical robotic technologies with a vision to make the benefits of robotic surgery affordable and accessible to a larger segment of the global population. The Company’s product range includes its proprietary “SSi Mantra” surgical robotic system and its comprehensive suite of “SSi Mudra” surgical instruments, which support a variety of robotic surgical procedures including cardiac surgery. An American company headquartered in India, SS Innovations plans to expand the global presence of its technologically advanced, user-friendly, and cost-effective surgical robotic solutions. Visit the Company’s website at ssinnovations.com or LinkedIn for more information and updates.</p>
<div class="lb-trans"><p>SS Innovations International, Inc.（纳斯达克：SSII）开发创新的外科机器人技术，旨在使机器人手术的好处对更大范围的全球人群变得经济实惠和可及。公司的产品范围包括其专有的 “SSi Mantra” 外科机器人系统和全面的 “SSi Mudra” 外科器械套件，支持包括心脏手术在内的多种机器人外科手术。SS Innovations 是一家总部位于印度的美国公司，计划扩大其技术先进、用户友好且经济实惠的外科机器人解决方案的全球影响力。有关更多信息和更新，请访问公司的官方网站 ssinnovations.com 或 LinkedIn。</p>
</div><p><strong>About the SSi Mantra</strong></p>
<div class="lb-trans"><p><strong>关于 SSi Mantra</strong></p>
</div><p>The SSi Mantra surgical robotic system is a user-friendly, modular, multi-arm system with many advanced technology features, including: 3 to 5 modular robotic arms, an open-faced ergonomic surgeon command center, a large 3D 4K monitor, a touch panel monitor for all patient related information display, a virtual real-time image of the robotic patient side arm carts, and the ability for superimposition of 3D models of diagnostic imaging. A vision cart provides the table-side team with the same magnified 3D 4K view as the surgeon to provide better safety and efficiency. The SSi Mantra utilizes over 40 different types of robotic endo-surgical instruments to support different specialties, including cardiac surgery. The SSi Mantra has been clinically validated in India in more than 100 different types of surgical procedures.</p>
<div class="lb-trans"><p>SSi Mantra 外科机器人系统是一个用户友好、模块化的多臂系统，具有许多先进的技术特性，包括：3 到 5 个模块化机器人手臂、开放式的人体工学外科医生指挥中心、大型 3D 4K 显示器、用于显示所有患者相关信息的触摸面板监视器、机器人患者侧手臂小车的虚拟实时图像，以及叠加诊断影像 3D 模型的能力。视觉车为桌边团队提供与外科医生相同的放大 3D 4K 视图，以提供更好的安全性和效率。SSi Mantra 利用超过 40 种不同类型的机器人内镜外科器械，支持包括心脏手术在内的不同专业。SSi Mantra 在印度的 100 多种不同类型的外科手术中得到了临床验证。</p>
</div><p><strong>Forward Looking Statements</strong></p>
<div class="lb-trans"><p><strong>前瞻性声明</strong></p>
</div><p>This press release may contain statements that are not historical facts and are considered forward-looking within the meaning of the Private Securities Litigation Reform Act of 1995. The words “anticipate,” “assume,” “believe,” “estimate,” “expect,” “will,” “intend,” “may,” “plan,” “project,” “should,” “could,” “seek,” “designed,” “potential,” “forecast,” “target,” “objective,” “goal,” or the negatives of such terms or other similar expressions to identify such forward-looking statements. These statements relate to future events or SS Innovations’ future financial performance and involve known and unknown risks, uncertainties and other factors that may cause our actual results, levels of activity, performance, or achievements to be materially different from any future results, levels of activity, performance or achievements expressed or implied by these forward-looking statements.</p>
<div class="lb-trans"><p>本新闻稿可能包含不属于历史事实的声明，并被视为 1995 年《私人证券诉讼改革法案》意义上的前瞻性声明。用 “预期”、“假设”、“相信”、“估计”、“期望”、“将”、“打算”、“可能”、“计划”、“项目”、“应该”、“可以”、“寻求”、“设计”、“潜在”、“预测”、“目标”、“目的”、“目标” 或这些术语的否定形式或其他类似表达来识别这些前瞻性声明。这些声明涉及未来事件或 SS Innovations 的未来财务表现，并涉及已知和未知的风险、不确定性和其他因素，这些因素可能导致我们的实际结果、活动水平、表现或成就与这些前瞻性声明所表达或暗示的任何未来结果、活动水平、表现或成就有实质性不同。</p>
</div><p><strong>Investor Contact:</strong></p>
<div class="lb-trans"><p><strong>投资者联系：</strong></p>
</div><p>The Equity Group</p>
<div class="lb-trans"><p>Equity Group</p>
</div><p>Kalle Ahl, CFA</p>
<div class="lb-trans"><p>Kalle Ahl, CFA</p>
</div><p>T: (303) 953-9878</p>
<div class="lb-trans"><p>电话：（303）953-9878</p>
</div><p>kahl@theequitygroup.com</p>
<div class="lb-trans"><p>kahl@theequitygroup.com</p>
</div><p>Devin Sullivan, Managing Director</p>
<div class="lb-trans"><p>德文·沙利文，董事总经理</p>
</div><p>T: (212) 836-9608</p>
<div class="lb-trans"><p>电话: (212) 836-9608</p>
</div><p>dsullivan@theequitygroup.com</p>
<div class="lb-trans"><p>电子邮件: dsullivan@theequitygroup.com</p>
</div><p><strong>Media Contact:</strong></p>
<div class="lb-trans"><p><strong>媒体联系人：</strong></p>
</div><p>RooneyPartners LLC</p>
<div class="lb-trans"><p>RooneyPartners LLC</p>
</div><p>Kate Barrette</p>
<div class="lb-trans"><p>Kate Barrette</p>
</div><p>T: (212) 223-0561</p>
<div class="lb-trans"><p>电话: (212) 223-0561</p>
</div><p>kbarrette@rooneypartners.com</p>
<div class="lb-trans"><p>电子邮件: kbarrette@rooneypartners.com</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.globenewswire.com/newsroom/ti/query-bmY9T1RZeU1qWXlNQ00zTXpVeU16Z3dJelV3TURFeU1ETTBPQT09" alt="" original-src="https://www.globenewswire.com/newsroom/ti?nf=OTYyMjYyMCM3MzUyMzgwIzUwMDEyMDM0OA=="/></p>
<p><img src="https://imageproxy.pbkrs.com/https://ml.globenewswire.com/media/MGVkOTQ3ODUtYzk5ZS00YTNiLTlhNGYtODY1MGU1MGI4NWJhLTUwMDEyMDM0OC0yMDI2LTAxLTA4LWVu/tiny/SS-Innovations.png" alt="" original-src="https://ml.globenewswire.com/media/MGVkOTQ3ODUtYzk5ZS00YTNiLTlhNGYtODY1MGU1MGI4NWJhLTUwMDEyMDM0OC0yMDI2LTAxLTA4LWVu/tiny/SS-Innovations.png"/></p>

SS Innovations 任命 Milan Rao 为全球首席运营官兼首席财务官 | SSII 股票新闻